Lunit Gets New Zealand Court's Preliminary Approval on Acquisition of Volpara Health koreabizwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from koreabizwire.com Daily Mail and Mail on Sunday newspapers.
Lunit, a Korean medical artificial intelligence (AI) startup, said Wednesday it has secured preliminary approval from a New Zealand high court for the acquisition of an Oceania-based breast cancer solution firm, Volpara Health.
Korean artificial intelligence-based cancer diagnostics company Lunit will acquire global breast cancer solutions provider Volpara Health, in a deal worth 252.5 billion won ($194.7 million), the company said Thursday. Lunit said this is the first time for it to join forces with another company via mergers and acquisitions, a significant step forward in realizing its mission to combat cancer with AI. Under the scheme .